These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18604950)

  • 1. Peptide-mediated targeting of liposomes to tumor cells.
    Rezler EM; Khan DR; Tu R; Tirrell M; Fields GB
    Methods Mol Biol; 2007; 386():269-98. PubMed ID: 18604950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and dynamics of peptide-amphiphiles incorporating triple-helical proteinlike molecular architecture.
    Yu YC; Roontga V; Daragan VA; Mayo KH; Tirrell M; Fields GB
    Biochemistry; 1999 Feb; 38(5):1659-68. PubMed ID: 9931034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted drug delivery utilizing protein-like molecular architecture.
    Rezler EM; Khan DR; Lauer-Fields J; Cudic M; Baronas-Lowell D; Fields GB
    J Am Chem Soc; 2007 Apr; 129(16):4961-72. PubMed ID: 17397150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The design of peptide-amphiphiles as functional ligands for liposomal anticancer drug and gene delivery.
    Kuang H; Ku SH; Kokkoli E
    Adv Drug Deliv Rev; 2017 Feb; 110-111():80-101. PubMed ID: 27539561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of peptide-amphiphiles possessing cellular activation sequences.
    Malkar NB; Lauer-Fields JL; Juska D; Fields GB
    Biomacromolecules; 2003; 4(3):518-28. PubMed ID: 12741765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipidated gemini peptide amphiphiles with enhanced loading capacity and cell membrane affinity for drug delivery.
    Yin X; Chen Z; Chen Y; Xie Y; Xiong B; Jiang H; Zhu J
    Colloids Surf B Biointerfaces; 2020 Nov; 195():111271. PubMed ID: 32736122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells.
    Adrian JE; Morselt HW; Süss R; Barnert S; Kok JW; Asgeirsdóttir SA; Ruiters MH; Molema G; Kamps JA
    J Control Release; 2010 Jun; 144(3):341-9. PubMed ID: 20226822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker.
    Gray BP; Li S; Brown KC
    Bioconjug Chem; 2013 Jan; 24(1):85-96. PubMed ID: 23186007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel tumor-targeted thermosensitive liposomal cerasome used for thermally controlled drug release.
    Li S; Yin G; Pu X; Huang Z; Liao X; Chen X
    Int J Pharm; 2019 Oct; 570():118660. PubMed ID: 31491484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
    Yuan M; Qiu Y; Zhang L; Gao H; He Q
    Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
    Shroff K; Kokkoli E
    Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Strategy Utilizing Extracellular Cysteine-Rich Domain of Membrane Receptor for Constructing d-Peptide Mediated Targeted Drug Delivery Systems: A Case Study on Fn14.
    Li Z; Xie J; Peng S; Liu S; Wang Y; Lu W; Shen J; Li C
    Bioconjug Chem; 2017 Aug; 28(8):2167-2179. PubMed ID: 28715634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Collagen-Model Triple-Helical Peptide-Amphiphiles for CD44-Targeted Drug Delivery Systems.
    Ndinguri MW; Zheleznyak A; Lauer JL; Anderson CJ; Fields GB
    J Drug Deliv; 2012; 2012():592602. PubMed ID: 23213537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chain-Length- and Saturation-Tuned Mechanics of Fluid Nanovesicles Direct Tumor Delivery.
    Dai Z; Yu M; Yi X; Wu Z; Tian F; Miao Y; Song W; He S; Ahmad E; Guo S; Zhu C; Zhang X; Li Y; Shi X; Wang R; Gan Y
    ACS Nano; 2019 Jul; 13(7):7676-7689. PubMed ID: 31187973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of the structural orientation of amide linkers on the serum compatibility and lung transfection properties of cationic amphiphiles.
    Srujan M; Chandrashekhar V; Reddy RC; Prabhakar R; Sreedhar B; Chaudhuri A
    Biomaterials; 2011 Aug; 32(22):5231-40. PubMed ID: 21501864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation.
    Nallamothu R; Wood GC; Pattillo CB; Scott RC; Kiani MF; Moore BM; Thoma LA
    AAPS PharmSciTech; 2006 Apr; 7(2):E32. PubMed ID: 16796350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities.
    Belfiore L; Saunders DN; Ranson M; Thurecht KJ; Storm G; Vine KL
    J Control Release; 2018 May; 277():1-13. PubMed ID: 29501721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption.
    Yamamoto S; Sakurai Y; Harashima H
    Int J Pharm; 2018 Jan; 536(1):42-49. PubMed ID: 29126905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.